Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels of specific cellular proteins

He joined Johns Hopkins in 2018 as the university's first vice provost for integrative learning and life design

The new platform gives you more intuitive, easier access to online professional development courses and other learning resources

An estimated crowd of 5,000 attended the Stand Up for Science event in the nation's capital, which featured three speakers from Johns Hopkins

NIH clinical trials are a lifeline for cancer patients like Baltimore native Vanessa, who received a groundbreaking immunotherapy treatment at the Kimmel Cancer Center